Oncology & Hematolgy: Early Engagement (Chapter 1 of 6)

Adam Callahan explains how early engagement can help sponsors build stronger oncology and hematology development strategies. Caidya can support planning before protocol development, including patient population selection, target product profiles, clinical development plans, and regulatory discussions. The conversation follows this support from pre-IND preparation and first-in-human studies through Phase II and Phase III trials. Adam also discusses how early collaboration helps teams anticipate regulatory questions, address stakeholder concerns, plan around standards of care, and identify potential operational risks. With oncology experience across its project management team, Caidya can help sponsors navigate key development decisions and prepare for timely study execution.